Clinical Trial Update: miR-342-5p/AnkG Pathway in Early AD Synaptic Dysfunction [NA]

View source ↗

Summary

This clinical trial update describes a recruiting study investigating the miR-342-5p/AnkG pathway in early synaptic dysfunction related to Alzheimer’s disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Conditions: Alzheimer Disease, Biomarker in Early Diagnosis | NA | Status: RECRUITING